Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.
about
Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory.Telomerase activity and clinical progression in chronic lymphoproliferative disorders of B-cell lineage.A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia.Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation.Telomeres and telomerase in hematologic neoplasia.Expression profile of telomere-associated genes in multiple myeloma.Telomere biology of human hematopoietic stem cells.The importance of the telomere and telomerase system in hematological malignancies.Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms.Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.Individual telomere lengths in chronic myeloid leukemia.Telomere dysfunction and its role in haematological cancer.Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.Knockdown of hTERT alters biophysical properties of K562 cells resulting in decreased migration rate in vitro.Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels.Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.Telomerase inhibiting activity in vitro from natural resources, marine algae extracts.Dynamic length changes of telomeres and their nuclear organization in chronic myeloid leukemia.A novel recurrent AML1-ETO fusion: tight in vivo association with BCR-ABL1.Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donors.Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage
P2860
Q34235845-BCB7EC9B-5B43-46FF-B5AF-6520946D8E2EQ34244517-01546A75-9350-4D0F-B1C5-CD4C22E4660BQ34383220-3BA0907C-74B2-40AF-A2FF-1C9BA66D3637Q34431569-37DE6F97-E582-4EF6-A22B-57E86B948603Q34535734-1379C4D1-6092-4349-B2A1-41855FEC1C2BQ35370390-538F50AD-B54C-485B-B752-0CE6F92D870EQ35692612-0632E03C-7D2B-458F-9801-3F70C70A6809Q36221550-213B8C48-E98D-4D37-8BC7-EE33CDC1DF60Q36267858-7FA1F729-9680-407D-801F-B3E9E0931255Q37010048-D5C66D44-2EE7-45E2-94BE-4ABA6E6341E7Q37399271-887B727A-F313-4372-A13D-17EE3EA33947Q37974664-3A252757-1C1F-4215-9CD2-DB44D693B118Q38342295-B97434D2-0F1D-460F-A751-35514DA8E68AQ39491897-B64EB893-EA5D-4296-9137-FCEEED0D43F4Q39556740-97060389-0B2B-42AD-BFAB-F18F6F695312Q39776035-B22895D2-D975-45F8-8113-0F5654BEA129Q42437893-4D3B88DB-6937-4D3C-9C22-0A24B22375B8Q42667277-B3BD94D5-4E7B-4D60-9915-28FB73E97504Q45309152-CEC058BC-AFA5-42CF-99CB-9078D7E0BE73Q46615370-36F9064F-D181-41F8-BD94-AAF8813205D0Q46960831-FB7FC4C4-96AF-49DD-9203-0615FB7EF488Q47752582-CA5CD827-5935-464D-BCF2-4DDC53CB5908Q54338593-DCCFD8F5-2DE7-47C5-8598-9093177ACBD3Q58276515-485510C7-0C75-4C13-AFC3-626FC08EFEA7
P2860
Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Telomerase activity and cytoge ...... emia with disease progression.
@en
Telomerase activity and cytoge ...... emia with disease progression.
@nl
type
label
Telomerase activity and cytoge ...... emia with disease progression.
@en
Telomerase activity and cytoge ...... emia with disease progression.
@nl
prefLabel
Telomerase activity and cytoge ...... emia with disease progression.
@en
Telomerase activity and cytoge ...... emia with disease progression.
@nl
P2093
P356
P1433
P1476
Telomerase activity and cytoge ...... emia with disease progression.
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2400560
P577
1997-02-01T00:00:00Z